Britannia Life Sciences Inc
CNSX:BLAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
McGraw Hill Inc
NYSE:MH
|
US |
|
Fuji PS Corp
TSE:1848
|
JP |
|
Sanyo Electric Railway Co Ltd
TSE:9052
|
JP |
|
Techmatrix Corp
TSE:3762
|
JP |
|
I
|
iSoftStone Information Technology Group Co Ltd
SZSE:301236
|
CN |
|
M
|
Manaksia Aluminium Co Ltd
NSE:MANAKALUCO
|
IN |
|
R
|
Rama Steel Tubes Ltd
NSE:RAMASTEEL
|
IN |
|
Z
|
Zhejiang Anglikang Pharmaceutical Co Ltd
SZSE:002940
|
CN |
|
J
|
Jiangsu Hongdou Industrial Co Ltd
SSE:600400
|
CN |
|
J
|
Jiankun International Bhd
KLSE:JIANKUN
|
MY |
|
GMO Financial Holdings Inc
TSE:7177
|
JP |
|
B
|
Bloom Energy Corp
SWB:1ZB
|
US |
|
Sos Ltd
NYSE:SOS
|
CN |
Britannia Life Sciences Inc
Total Current Assets
Britannia Life Sciences Inc
Total Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Britannia Life Sciences Inc
CNSX:BLAB
|
Total Current Assets
CA$9.9m
|
CAGR 3-Years
42%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
High Tide Inc
XTSX:HITI
|
Total Current Assets
CA$134.6m
|
CAGR 3-Years
28%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
|
Canopy Growth Corp
TSX:WEED
|
Total Current Assets
CA$524.7m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
27%
|
|
|
Aurora Cannabis Inc
TSX:ACB
|
Total Current Assets
CA$445.8m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
60%
|
|
|
Sundial Growers Inc
NASDAQ:SNDL
|
Total Current Assets
CA$449.6m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
|
Cronos Group Inc
TSX:CRON
|
Total Current Assets
$944.1m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
100%
|
|
Britannia Life Sciences Inc
Glance View
Britannia Life Sciences, Inc. is a global product development platform. The company is headquartered in Toronto, Ontario. The company went IPO on 2017-12-01. The firm's platform offers an integrated suite of services to assist companies along their product development journey. The firm provides product formulations, safety assessments, analytical and microbiological testing, global compliance and consumer evaluations to the cosmetic, consumer packaged goods and nutraceutical industries in the United Kingdom and globally. The company is also engaged in the development and regulatory approval of topical and edible cannabis products, including preparation and support for food authorizations. The company serves consumer packaged goods (CPG), cosmetics, household goods and nutraceutical industries, blue-chip, food and beverage, nutraceutical sectors, toiletries, small and medium enterprise (SME) clients.
See Also
What is Britannia Life Sciences Inc's Total Current Assets?
Total Current Assets
9.9m
CAD
Based on the financial report for Mar 31, 2025, Britannia Life Sciences Inc's Total Current Assets amounts to 9.9m CAD.
What is Britannia Life Sciences Inc's Total Current Assets growth rate?
Total Current Assets CAGR 3Y
42%
Over the last year, the Total Current Assets growth was 264%. The average annual Total Current Assets growth rates for Britannia Life Sciences Inc have been 42% over the past three years .
